PExA signs agreement with global pharmaceutical company for 10 instruments for clinical multicenter study in pulmonary fibrosis, with a value of approximately SEK 7.5 million
PExA AB has signed an agreement with one of the world’s ten largest pharmaceutical companies regarding the delivery, installation and rental of ten PExA 2.1 systems for use in...
Read more